Pilho Kim

2.1k total citations
43 papers, 1.6k citations indexed

About

Pilho Kim is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Pilho Kim has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Organic Chemistry and 7 papers in Infectious Diseases. Recurrent topics in Pilho Kim's work include Cancer therapeutics and mechanisms (13 papers), Synthesis and Biological Evaluation (7 papers) and Tuberculosis Research and Epidemiology (6 papers). Pilho Kim is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Synthesis and Biological Evaluation (7 papers) and Tuberculosis Research and Epidemiology (6 papers). Pilho Kim collaborates with scholars based in South Korea, United States and India. Pilho Kim's co-authors include Clifton E. Barry, Ujjini H. Manjunatha, Helena I. Boshoff, Ramandeep Singh, Jan Jiřiček, Thomas H. Keller, Cynthia S. Dowd, Sun‐Hee Kang, Pornwaratt Niyomrattanakit and Ill Young Lee and has published in prestigious journals such as Science, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Pilho Kim

41 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pilho Kim South Korea 18 653 547 514 488 90 43 1.6k
Marco Pieroni Italy 23 771 1.2× 493 0.9× 332 0.6× 683 1.4× 112 1.2× 58 1.6k
Éric Arnoult United States 11 590 0.9× 572 1.0× 415 0.8× 376 0.8× 103 1.1× 17 1.4k
Alessandro De Logu Italy 31 778 1.2× 598 1.1× 470 0.9× 949 1.9× 115 1.3× 62 2.3k
Peter B. Madrid United States 26 659 1.0× 740 1.4× 282 0.5× 474 1.0× 89 1.0× 47 1.9k
Vincent Delorme France 19 482 0.7× 452 0.8× 300 0.6× 148 0.3× 79 0.9× 32 1.0k
Vikram Saini India 25 546 0.8× 480 0.9× 398 0.8× 150 0.3× 47 0.5× 40 1.4k
Vinayak Singh South Africa 21 559 0.9× 518 0.9× 250 0.5× 263 0.5× 65 0.7× 51 1.1k
Leo Einck United States 21 847 1.3× 735 1.3× 519 1.0× 273 0.6× 58 0.6× 36 1.6k
Nicolas Willand France 20 606 0.9× 411 0.8× 193 0.4× 408 0.8× 120 1.3× 58 1.2k
Vladimı́r Buchta Czechia 26 544 0.8× 399 0.7× 279 0.5× 1.1k 2.4× 151 1.7× 96 2.0k

Countries citing papers authored by Pilho Kim

Since Specialization
Citations

This map shows the geographic impact of Pilho Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilho Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilho Kim more than expected).

Fields of papers citing papers by Pilho Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilho Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilho Kim. The network helps show where Pilho Kim may publish in the future.

Co-authorship network of co-authors of Pilho Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Pilho Kim. A scholar is included among the top collaborators of Pilho Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilho Kim. Pilho Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Yonghyo, et al.. (2025). Discovery of novel benzosultam CRBN ligands. Bulletin of the Korean Chemical Society. 46(1). 48–56.
2.
Kim, Eun Hye, et al.. (2024). Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation. PLoS ONE. 19(6). e0305261–e0305261. 3 indexed citations
3.
Kim, Seulgi, Yuri Choi, Jin Hwan Kim, et al.. (2022). Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model. Bioorganic Chemistry. 127. 105923–105923. 17 indexed citations
4.
Kim, Jee‐Heun, So‐Yeon Park, Jang-Hyun Choi, et al.. (2022). DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis. Theranostics. 12(12). 5258–5271. 24 indexed citations
5.
Lee, Chong Ock, et al.. (2017). Novel 2,4-diaminopyrimidines bearing fused tricyclic ring moiety for anaplastic lymphoma kinase (ALK) inhibitor. Bioorganic & Medicinal Chemistry Letters. 27(10). 2185–2191. 11 indexed citations
6.
Kang, Chung Hyo, Heung Kyoung Lee, Ha-Yeon Lee, et al.. (2016). Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R. European Journal of Medicinal Chemistry. 126. 536–549. 14 indexed citations
7.
Kang, Chung Hyo, Kwangho Lee, Chong Ock Lee, et al.. (2015). Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins. Biochemical and Biophysical Research Communications. 464(3). 762–767. 4 indexed citations
8.
Park, Chi-Min, Joo Yun Lee, Jae Du Ha, et al.. (2015). Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors. Bioorganic & Medicinal Chemistry. 24(2). 207–219. 11 indexed citations
9.
Kim, Pilho, Deok‐Sun Lee, & B. Kahng. (2015). Biconnectivity of the cellular metabolism: A cross-species study and its implication for human diseases. Scientific Reports. 5(1). 15567–15567. 2 indexed citations
10.
Jang, Ye Jin, Hye Won Lee, Hyo Jin Lee, et al.. (2014). Synthesis and anti-influenza virus activity of 4-oxo- or thioxo-4,5-dihydrofuro[3,4-c]pyridin-3(1H)-ones. Antiviral Research. 107. 66–75. 19 indexed citations
11.
Kim, Meehyein, Soyeon Kim, Hye Won Lee, et al.. (2013). Inhibition of influenza virus internalization by (−)-epigallocatechin-3-gallate. Antiviral Research. 100(2). 460–472. 109 indexed citations
12.
Kapilashrami, Kanishk, et al.. (2013). Thiolactomycin-based β-Ketoacyl-AcpM Synthase A (KasA) Inhibitors. Journal of Biological Chemistry. 288(9). 6045–6052. 27 indexed citations
13.
Kim, Pilho, Deok‐Sun Lee, & B. Kahng. (2013). Phase transition in the biconnectivity of scale-free networks. Physical Review E. 87(2). 22804–22804. 3 indexed citations
14.
Malpani, Yashwardhan R., So Yeon Kim, Pilho Kim, et al.. (2013). Efficient synthesis of 3 H ,3′ H -spiro[benzofuran-2,1′-isobenzofuran]-3,3′-dione as novel skeletons specifically for influenza virus type B inhibition. European Journal of Medicinal Chemistry. 62. 534–544. 53 indexed citations
15.
Kim, Suhyun, Sang-Nae Cho, Taegwon Oh, & Pilho Kim. (2012). Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents. Bioorganic & Medicinal Chemistry Letters. 22(22). 6844–6847. 42 indexed citations
16.
Lee, Sang‐Ho, Suhyun Kim, Yong Sup Lee, et al.. (2011). Synthesis and antitubercular activity of monocyclic nitroimidazoles: Insights from econazole. Bioorganic & Medicinal Chemistry Letters. 21(5). 1515–1518. 36 indexed citations
17.
Singh, Ramandeep, Ujjini H. Manjunatha, Helena I. Boshoff, et al.. (2008). PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release. Science. 322(5906). 1392–1395. 491 indexed citations
18.
Kim, Pilho, Clifton E. Barry, & Cynthia S. Dowd. (2006). Novel route to 5-position vinyl derivatives of thiolactomycin: olefination versus deformylation. Tetrahedron Letters. 47(20). 3447–3451. 11 indexed citations
19.
Dowd, Cynthia S., et al.. (2004). Synthesis and Spectroscopic Differentiation of 2- and 4-Alkoxythio-tetronic Acids. Heterocycles. 63(3). 519–519. 8 indexed citations
20.
Kim, Pilho, et al.. (1996). Association of Invasive Pneumococcal Disease with Season, Atmospheric Conditions, Air Pollution, and the Isolation of Respiratory Viruses. Clinical Infectious Diseases. 22(1). 100–106. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026